> Health Plans
> Clinical Trials
> Medical Research
KONZA helps our customers connect to the world. As a member of eHealth Exchange KONZA works with health care providers across the nation to design custom solutions to meet their unique needs. KONZA connects health care systems together to share data internally and with external partners such as the Veterans Administration, Military Health Services, CVS, DaVita, Yale New Haven Health, and many others.
Health plans are striving to move away from antiquated analytics based on claims data and manual chart chasing solutions that are expensive and time consuming. To achieve success new regulations and payment models require health plans to have near real time data for their members. KONZA offers a suite of solutions for health plans that include data acquisition, aggregation and curation for historical and real time member data. The KONZA clinical platform is certified for 2019/2020 NCQA HEDIS reporting.
KONZA also provides best-in-class management consulting expertise to support health plans in determining health IT solutions for the aggregations and management of electronic medical records. KONZA has experience is designing health IT solutions for some of the largest health plans in the nation.
KONZA maintains one of the largest clinical data warehouses in the nation. KONZA makes healthcare data available for purposes of medical research in limited data sets and de-identified data sets. KONZA data has been used by some of the largest medical research centers in the nation to develop medical products and services that require large, longitudinal data sets.
KONZA utilizes its vast clinical data warehouse to identify patients for clinical trials. KONZA’s patient recruitment solution respects the physician-patient relationship while ensuring patients with unique or rare diseases know they are eligible to participate. KONZA provides pre-screened patients to clinical trial sites and KONZA’s unique platform allows sites to monitor patient’s medical care prior, during and after the trial with patient consent.